5.46 - 5.64
4.95 - 8.28
2.0K / 2.4K (Avg.)
-282.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-7.34%
Negative revenue growth while VALMT.HE stands at 19.39%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-27.70%
Negative gross profit growth while VALMT.HE is at 24.35%. Joel Greenblatt would examine cost competitiveness or demand decline.
-44.39%
Negative EBIT growth while VALMT.HE is at 60.82%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-44.39%
Negative operating income growth while VALMT.HE is at 60.82%. Joel Greenblatt would press for urgent turnaround measures.
-35.91%
Negative net income growth while VALMT.HE stands at 70.42%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-36.36%
Negative EPS growth while VALMT.HE is at 69.23%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-36.36%
Negative diluted EPS growth while VALMT.HE is at 73.68%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.28%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.43%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
5.72%
Positive OCF growth while VALMT.HE is negative. John Neff would see this as a clear operational advantage vs. the competitor.
-152.97%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
2.28%
10Y revenue/share CAGR under 50% of VALMT.HE's 34.61%. Michael Burry would suspect a lasting competitive disadvantage.
33.94%
5Y revenue/share CAGR similar to VALMT.HE's 32.21%. Walter Schloss might see both companies benefiting from the same mid-term trends.
14.59%
3Y revenue/share CAGR similar to VALMT.HE's 13.34%. Walter Schloss would assume both companies experience comparable short-term cycles.
293.42%
10Y OCF/share CAGR above 1.5x VALMT.HE's 87.01%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
-33.32%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-28.40%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
63.39%
Below 50% of VALMT.HE's 1531.64%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
80.25%
5Y net income/share CAGR at 50-75% of VALMT.HE's 111.28%. Martin Whitman might see a shortfall in operational efficiency or brand power.
324.81%
3Y net income/share CAGR above 1.5x VALMT.HE's 22.86%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
109.80%
Below 50% of VALMT.HE's 385.45%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
79.73%
5Y equity/share CAGR at 50-75% of VALMT.HE's 116.03%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
42.21%
Below 50% of VALMT.HE's 94.96%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-20.44%
Firm’s AR is declining while VALMT.HE shows 9.30%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-1.38%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
2.21%
Positive asset growth while VALMT.HE is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
6.24%
BV/share growth above 1.5x VALMT.HE's 2.42%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-2.52%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
33.58%
We expand SG&A while VALMT.HE cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.